Intellia Therapeutics (NTLA)
Today’s Chart of the Week comes from our Under the Hood Report, which aggregates data points to identify significant increase in investor attention.
We are looking at Intellia Therapeutics (NTLA), a midcap biotech stock we believe is ready to break out.
NTLA is showing strong relative strength, in a great sector, and as long as it’s above that 71 level, is breaking out to the upside.
We are long on NTLA above (and only above) $71.
Below that, it’s not a breakout.
We have target of $110, giving us 39 points profit (55% gain whoop whoop) with minimal risk — our favorite type of trade.
Til next week, good trading,
Free Training: 60-Minutes to Trading Freedom
Would you like to make more money in one hour of fun trading than working all day at a job?
Then check this out…